首页 正文

Effects of CTLA4-Ig, rituximab, and rapamycin on rat-to-mouse cardiac xenograft survival

{{output}}
Background: Xenotransplantation addresses the critical shortage of human organs and tissues; however, innate immune responses and acute humoral rejection (AHR) limit xenograft survival, the regimen of combined medication remains ... ...